- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
IT Dept searches offices, manufacturing facilities of Akums Drugs, its subsidiaries
New Delhi: The Income Tax Department has searched the offices and manufacturing units of a contract development and manufacturing organisation (CDMO) Akums Drugs and Pharmaceuticals Limited and its subsidiaries, the company informed in a recent BSE filing.
The search was conducted under the Income Tax Act, 1961.
"We have fully cooperated with the officials of IT Department during the search and responded to the clarifications and details sought by them. We will continue to provide any further clarification/information that may be required," the Company stated..
Further, Akum stated, "Akums is a law-abiding Company and follows the best corporate governance practices," it added.
"We have extended our full cooperation to the officials of the IT Department in this regard. The business operations of the Company continue as usual except some minor hiccups. We will comply with legal obligation in relation to disclosure(s) from time to time," it added.
Established in 2004, Akums is a Contract Development and Manufacturing Organization (CDMO). In FY23, Akums captured a 9.3% market share by value in the Indian domestic CDMO market, with an 8.8% share by volume in the Indian Pharmaceutical Market (IPM). By FY24, its market share by value increased to 10.0%, with a significant 30.2% share by value within the domestic CDMO market. Akums operates 15 state-of-the-art facilities producing a wide range of modern dosage forms across multiple therapeutic segments.
The company offers a comprehensive suite of advanced services, including formulation development, bioequivalence studies, clinical trials, and securing Drug Controller General of India (DCGI) approvals for manufacturing and marketing new Fixed Dose Combinations (FDCs) and molecules.
Read also: Income Tax dept imposes Rs 2.3 crore penalty on Torrent Pharma
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751